Boston Trust Walden Corp Merck & Co., Inc. Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 635,524 shares of MRK stock, worth $63.6 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

635,524

Previous 641,984 1.01%

Holding current value

$63.6 Million

Previous $79.5 Million 9.19%

% of portfolio

0.51%

Previous 0.6%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$111.15 - $128.97 $718,029 - $833,146	-6,460 Reduced 1.01%	635,524 $72.2 Million
Q2 2024 Jul 19, 2024	SELL	$123.8 - $132.96 $4.9 Million - $5.26 Million	-39,559 Reduced 5.8%	641,984 $79.5 Million
Q1 2024 Apr 22, 2024	SELL	$113.24 - $131.95 $9.81 Million - $11.4 Million	-86,608 Reduced 11.27%	681,543 $89.9 Million
Q4 2023 Jan 24, 2024	BUY	$100.18 - $109.02 $1.83 Million - $2 Million	18,309 Added 2.44%	768,151 $83.7 Million
Q3 2023 Oct 18, 2023	SELL	$102.95 - $114.33 $217,327 - $241,350	-2,111 Reduced 0.28%	749,842 $77.2 Million
Q2 2023 Jul 24, 2023	SELL	$108.61 - $118.38 $137,934 - $150,342	-1,270 Reduced 0.17%	751,953 $86.8 Million
Q1 2023 Apr 19, 2023	SELL	$102.94 - $114.86 $3.46 Million - $3.86 Million	-33,579 Reduced 4.27%	753,223 $80.1 Million
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $1.02 Million - $1.31 Million	-11,720 Reduced 1.47%	786,802 $0
Q3 2022 Oct 19, 2022	SELL	$84.53 - $94.96 $504,644 - $566,911	-5,970 Reduced 0.74%	798,522 $68.8 Million
Q2 2022 Jul 22, 2022	SELL	$83.49 - $94.64 $1.2 Million - $1.36 Million	-14,423 Reduced 1.76%	804,492 $73.3 Million
Q1 2022 Apr 20, 2022	BUY	$73.51 - $82.4 $445,691 - $499,591	6,063 Added 0.75%	818,915 $67.2 Million
Q4 2021 Jan 21, 2022	SELL	$72.28 - $90.54 $2.65 Million - $3.32 Million	-36,715 Reduced 4.32%	812,852 $62.3 Million
Q3 2021 Oct 25, 2021	BUY	$71.68 - $78.83 $879,656 - $967,401	12,272 Added 1.47%	849,567 $63.8 Million
Q2 2021 Jul 22, 2021	BUY	$70.31 - $77.77 $3.63 Million - $4.02 Million	51,686 Added 6.58%	837,295 $65.1 Million
Q1 2021 Apr 21, 2021	BUY	$68.86 - $81.11 $8.55 Million - $10.1 Million	124,122 Added 18.76%	785,609 $60.6 Million
Q4 2020 Jan 15, 2021	BUY	$71.77 - $79.65 $372,916 - $413,861	5,196 Added 0.79%	661,487 $54.1 Million
Q3 2020 Oct 14, 2020	BUY	$73.18 - $82.95 $326,016 - $369,542	4,455 Added 0.68%	656,291 $54.4 Million
Q2 2020 Jul 23, 2020	BUY	$70.42 - $80.13 $1.59 Million - $1.81 Million	22,587 Added 3.59%	651,836 $50.4 Million
Q1 2020 Apr 21, 2020	SELL	$63.36 - $87.82 $108,408 - $150,260	-1,711 Reduced 0.27%	629,249 $48.4 Million
Q4 2019 Jan 10, 2020	BUY	$77.58 - $87.54 $225,602 - $254,566	2,908 Added 0.46%	630,960 $57.4 Million
Q3 2019 Oct 21, 2019	SELL	$76.08 - $82.93 $242,847 - $264,712	-3,192 Reduced 0.51%	628,052 $52.9 Million
Q2 2019 Jul 25, 2019	BUY	$69.84 - $81.59 $763,071 - $891,452	10,926 Added 1.76%	631,244 $52.9 Million
Q1 2019 Apr 16, 2019	BUY	$69.58 - $79.36 $978,990 - $1.12 Million	14,070 Added 2.32%	620,318 $51.6 Million
Q4 2018 Jan 17, 2019	SELL	$65.24 - $75.71 $668,188 - $775,421	-10,242 Reduced 1.66%	606,248 $46.3 Million
Q3 2018 Oct 23, 2018	SELL	$57.69 - $67.84 $268,546 - $315,795	-4,655 Reduced 0.75%	616,490 $43.7 Million
Q2 2018 Jul 25, 2018	SELL	$50.83 - $59.72 $87,529 - $102,837	-1,722 Reduced 0.28%	621,145 $37.7 Million
Q1 2018 Apr 13, 2018	SELL	$50.96 - $59.23 $525,550 - $610,838	-10,313 Reduced 1.63%	622,867 $33.9 Million
Q4 2017 Jan 29, 2018	SELL	$51.62 - $61.64 $1.25 Million - $1.49 Million	-24,175 Reduced 3.68%	633,180 $35.6 Million
Q3 2017 Oct 13, 2017	BUY	$58.67 - $63.13 $38.6 Million - $41.5 Million	657,355	657,355 $42.1 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Merck & Co., Inc. Transaction History